Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

HKG/6887 stock hub

HKG/6887 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HKG/6887is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

24.4B

Hong Kong Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

HKG/6887

In the news

Latest news · HKG/6887

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11.7P50 18.9P75 41.4

Trailing P/E69.2

P25 10.7P50 17.9P75 38.5

ROE4.2

P25 -14.7P50 2P75 9.4

ROIC5.7

P25 -10.4P50 1.9P75 10.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HKG/6887 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

201

Groups with data

Currency

CNY

Showing 201 of 201 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	HK
Employees	6,353
Employees Change	1,492%
Employees Change Percent	30.69
Enterprise value	HKD 27.9B
Exchange	Hong Kong Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Last refreshed	2026-05-10
Market cap	HKD 24.4B
Price	HKD 42.36
Price currency	HKD
Rev Per Employee	843,421.01x
Sector	Healthcare
Sic	2834
Symbol	hkg/6887
Website	https://www.hecpharm.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.24%
EV Earnings	92.11x
EV/EBIT	36.31x
EV/EBITDA	23.35x
EV/Sales	5.21x
P/B ratio	5.05x
P/E ratio	69.21x
P/S ratio	4.55x
PE Ratio10 Y	24.87x
PE Ratio3 Y	37.62x
PE Ratio5 Y	24.57x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	14.35%
EBITDA Margin	22.32%
Gross margin	76.54%
Gross Profit	HKD 4.1B
Gross Profit Growth	66.02%
Gross Profit Growth Q	162.51%
Gross Profit Growth3 Y	-6.19%
Gross Profit Growth5 Y	-3.7%
Net Income	HKD 303.2M
Net Income Growth	-43.56%
Net Income Growth3 Y	-37.3%
Net Income Growth5 Y	-24.88%
Pretax Margin	9.13%
Profit Margin	5.66%
Profit Per Employee	HKD 47,722
ROA	3.54
Roa5y	3.99
ROCE	11.61
ROE	4.2
Roe5y	5.36
ROIC	5.65
Roic5y	7.26

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	6.3%
Cagr1y	-4.41%
Cagr3y	20.71%
Cagr5y	12.28%
Div CAGR3	0%
Div CAGR5	0%
EPS Growth	-73.57
EPS Growth3 Y	-44.8
EPS Growth5 Y	-35.45
Revenue Growth	29.31x
Revenue Growth Q	126.74x
Revenue Growth3 Y	-5.29x
Revenue Growth5 Y	-3.18x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	HKD 0.39
Assets	HKD 13.3B
Cash	HKD 1.7B
Current Assets	HKD 5.4B
Current Liabilities	HKD 7B
Debt	HKD 5.2B
Debt EBITDA	HKD 4.35
Debt Equity	HKD 1.08
Equity	HKD 4.8B
Interest Coverage	3
Liabilities	HKD 8.5B
Long Term Assets	HKD 8B
Long Term Liabilities	HKD 1.6B
Net Cash	HKD -3.5B
Net Cash By Market Cap	HKD -14.49
Net Debt EBITDA	HKD 2.96
Net Debt Equity	HKD 0.73
Tangible Book Value	HKD 4B
Tangible Book Value Per Share	HKD 6.86
WACC	3.58

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.77
Inventory Turnover	1.58
Net Working Capital	HKD 395.2M
Quick ratio	0.56
Working Capital	HKD -1.5B
Working Capital Turnover	HKD 13.3

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-114.82%
Dividend Growth	0%
Dividend Growth Years	1%
Dividend per share	HKD 5.69
Dividend Years	1
Dividend Yield	12.74%
Ex Div Date	2025-07-31
Last Dividend	HKD 5.69
Payout Frequency	Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	84.12%
1Y total return	-4.41%
200-day SMA	47.32
3Y total return	75.91%
50-day SMA	42.78
50-day SMA vs 200-day SMA	50under200
5Y total return	78.46%
All Time High	103.3
All Time High Change	-58.98%
All Time High Date	2020-01-21
All Time Low	12.71
All Time Low Change	233.33%
All Time Low Date	2021-11-02
ATR	1.72
Beta	-0.1
Beta1y	0.36
Beta2y	0.14
Ch YTD	-7.11
High	42.58
High52	67.3
High52 Date	2025-07-18
High52ch	-37.05%
Low	42
Low52	39.8
Low52 Date	2026-03-04
Low52ch	6.43%
Ma50ch	-0.99%
Price vs 200-day SMA	-10.47%
RSI	46.69
RSI Monthly	50.24
RSI Weekly	44.81
Sharpe ratio	0.21x
Sortino ratio	0.48
Total Return	-102.08%
Tr YTD	-7.11
Tr1m	-3.42%
Tr1w	-7.55%
Tr3m	1%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	HKD 769.1M
Operating Income Growth	309.2
Operating Income Growth3 Y	-29.87
Operating Income Growth5 Y	-14.92
Operating margin	14.35

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	106,250,065%
Shares Insiders	0.01%
Shares Institutions	2.85%
Shares Out	575,978,447
Shares Qo Q	26%
Shares Yo Y	114.82%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	259,070.8x
Bv Per Share	8.38
Ch10y	44.09
Ch1m	-3.42
Ch1w	-7.55
Ch1y	-13.44
Ch3m	1
Ch3y	59.3
Ch5y	61.6
Ch6m	-13.62
Change	-0.7%
Change From Open	-0.33
Close	42.66
Days Gap	-0.38
Depreciation Amortization	441,668,189.6
Dollar Volume	7,041,968.8
Earnings Date	2026-08-28
EBIT	HKD 769.1M
EBITDA	HKD 1.2B
EPS	HKD 0.61
F Score	5
Fiscal Year End	December
Founded	2,001
Graham Number	10.74501
Graham Upside	-74.63
Income Tax	HKD 188.7M
Is Primary Listing	1
Last Earnings Date	2026-03-31
Last Report Date	2025-12-31
Last Split Date	2025-08-06
Last Split Type	Reverse
Lynch Fair Value	HKD 3.06
Lynch Upside	-92.78
Ma150	44.55
Ma150ch	-4.92%
Ma20	43.3
Ma20ch	-2.17%
Next Earnings Date	2026-08-28
Open	42.5
Payment Date	2025-10-31
Position In Range	62.07
Ppne	4,962,971,892.1
Price Date	2026-05-08
Price EBITDA	HKD 20.4
Ptbv Ratio	6.17
Relative Volume	0.64x
Revenue	5,358,253,677x
Tax By Revenue	3.52x
Tax Rate	38.57%
Tr6m	-13.62%
Volume	166,241
Z Score	1.66

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

HKG/6887 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+12.7%

$5.69 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

0.0%

1 consecutive years of growth

Total shareholder yield

-102.1%

Next ex-dividend date: 2025-07-31

Performance

HKG/6887 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns HKG/6887?

Insider, institutional, and short-interest positioning.

Institutional ownership

+2.8%

Share of float held by funds and institutions

Insider ownership

+0.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+114.8%

Negative means the company is buying back shares.

Technical

HKG/6887 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

46.7

Neutral momentum band

Price vs 200-day MA

-10.5%

50/200-day relationship not available

Beta (5Y)

-0.10

Less volatile than the market

Sharpe ratio

0.21

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HKG/6887

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hkg/6887 stock rating?

hkg/6887 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hkg/6887 analysis?

The full report lives at /stocks/hkg/6887/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hkg/6887?

The latest report frames hkg/6887 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hkg/6887 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.